Long-term postnatal outcome of fetuses with prenatally suspected septo-optic dysplasia.


Journal

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
ISSN: 1469-0705
Titre abrégé: Ultrasound Obstet Gynecol
Pays: England
ID NLM: 9108340

Informations de publication

Date de publication:
09 2020
Historique:
received: 16 01 2020
accepted: 07 03 2020
pubmed: 21 3 2020
medline: 8 9 2021
entrez: 21 3 2020
Statut: ppublish

Résumé

Septo-optic dysplasia (SOD) is a clinical syndrome characterized by varying combinations of optic nerve hypoplasia, pituitary gland hypoplasia and abnormal cavum septi pellucidi. It is suspected on prenatal imaging when there is non-visualization or hypoplasia of the septal leaflets. Long-term postnatal outcomes of fetuses with prenatally suspected SOD have been documented poorly. The aims of this study were to describe the natural history of deficient septal leaflets, to quantify the incidence of postnatally confirmed SOD and to document the visual, endocrine and long-term neurodevelopmental outcomes of these infants. This was an observational retrospective study of all fetuses with prenatal imaging showing isolated septal agenesis, assessed at a single tertiary center over an 11-year period. Pregnancy, delivery and neonatal outcomes and pre- and postnatal imaging findings were reviewed. Neonatal evaluations or fetal autopsy reports were assessed for confirmation of SOD. Ophthalmologic, endocrine, genetic and long-term developmental evaluations were assessed. Imaging findings and outcome were compared between infants with and those without postnatally confirmed SOD. Of 214 fetuses presenting with septal absence on prenatal ultrasound and magnetic resonance imaging (MRI), 18 (8.4%) were classified as having suspected isolated septal agenesis suspicious for SOD. Uniform prenatal MRI findings in cases with suspected SOD included remnants of the leaflets of the cavum septi pellucidi, fused forniceal columns, normal olfactory bulbs and tracts and a normal optic chiasm. Twelve fetuses were liveborn and five (27.8%) had postnatally confirmed SOD. Only two of these five fetuses had additional prenatal imaging features (pituitary cyst, microphthalmia and optic nerve hypoplasia) supporting a diagnosis of SOD. The other three confirmed SOD cases had no predictive prenatal or postnatal imaging findings that reliably differentiated them from cases without confirmed SOD. Visual and endocrine impairments were present in two (40%) and four (80%) cases with confirmed SOD, respectively. In those with visual and/or endocrine impairment, developmental delay (median age at follow-up, 2.5 (interquartile range, 2.5-7.0) years) was common (80%) and mostly severe. Neonates with isolated septal agenesis and a lack of visual or endocrine abnormalities to confirm SOD had normal development. Only a quarter of fetuses with isolated septal agenesis suggestive of SOD will have postnatal confirmation of the diagnosis. Clinical manifestations of SOD are variable, but neurodevelopmental delay may be more prevalent than thought formerly. © 2020 Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Identifiants

pubmed: 32196785
doi: 10.1002/uog.22018
pmc: PMC7496228
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

371-377

Informations de copyright

© 2020 Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Références

BMC Med Genet. 2019 Jun 24;20(1):112
pubmed: 31234783
Radiology. 1989 Apr;171(1):189-92
pubmed: 2928524
Adv Pediatr. 2016 Aug;63(1):127-46
pubmed: 27426898
AJR Am J Roentgenol. 1989 Feb;152(2):353-60
pubmed: 2783514
Ultraschall Med. 2019 Aug;40(4):476-480
pubmed: 29879744
Ultrasound Obstet Gynecol. 2016 Dec;48(6):727-732
pubmed: 27514863
Prenat Diagn. 2010 Dec;30(12-13):1143-50
pubmed: 20936603
J Pediatr. 1979 Jan;94(1):162-3
pubmed: 758405
Horm Res. 2000;53 Suppl 1:19-25
pubmed: 10895038
Psychiatry Res. 2010 Feb 28;181(2):108-13
pubmed: 20074913
Pediatr Endocrinol Rev. 2008 Mar;5(3):772-7
pubmed: 18367998
J Child Neurol. 2018 Oct;33(11):693-699
pubmed: 29944054
Prenat Diagn. 2018 May;38(6):395-401
pubmed: 29532939
J Clin Endocrinol Metab. 2012 Apr;97(4):E694-9
pubmed: 22319038
Eur J Pediatr. 1999 Feb;158(2):97-102
pubmed: 10048603
Ultrasound Obstet Gynecol. 2012 Aug;40(2):165-70
pubmed: 22689012
J Child Neurol. 2017 Aug;32(9):797-803
pubmed: 28482731
Clin Case Rep. 2017 Mar 02;5(4):463-470
pubmed: 28396770
J Pediatr. 2006 Jan;148(1):85-8
pubmed: 16423603
Ultrasound Obstet Gynecol. 2011 May;37(5):570-5
pubmed: 20878682
Ultrasound Obstet Gynecol. 2005 Jan;25(1):73-5
pubmed: 15593257
Ultrasound Obstet Gynecol. 2005 Jan;25(1):42-9
pubmed: 15593321
Ultrasound Obstet Gynecol. 2019 Nov 11;:
pubmed: 31710738
Brain Dev. 1986;8(3):233-9
pubmed: 3766900
Pituitary. 2007;10(4):393-407
pubmed: 17587179
Clin Pediatr Endocrinol. 2017;26(2):89-98
pubmed: 28458461

Auteurs

S Shinar (S)

Ontario Fetal Centre, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.

S Blaser (S)

Department of Diagnostic Imaging, Hospital for Sick Children, Department of Medical Imaging, University of Toronto, Toronto, ON, Canada.

D Chitayat (D)

Prenatal Diagnosis and Medical Genetics Program, Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
Division of Clinical and Metabolic Genetics, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

T Selvanathan (T)

Department of Paediatrics, Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.

V Chau (V)

Department of Paediatrics, Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.

P Shannon (P)

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.

S Agrawal (S)

Ontario Fetal Centre, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.

G Ryan (G)

Ontario Fetal Centre, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.

V Pruthi (V)

Ontario Fetal Centre, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.

S P Miller (SP)

Department of Paediatrics, Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.

P Krishnan (P)

Department of Diagnostic Imaging, Hospital for Sick Children, Department of Medical Imaging, University of Toronto, Toronto, ON, Canada.

T Van Mieghem (T)

Ontario Fetal Centre, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH